Kalevi Kairemo

Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers

Tuuli Ranki, Sari Pesonen, Akseli Hemminki et al. · Journal for ImmunoTherapy of Cancer · 2016 · 202 citations · Full text

Pharmacy, Immunology, Oncology +17

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

Anna Kanerva, Petri Nokisalmi, Iulia Diaconu et al. · Clinical Cancer Research · 2013 · 177 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Sari Pesonen, Iulia Diaconu, Lotta Kangasniemi et al. · Cancer Research · 2012 · 138 citations · Full text

Medicine, Immunology, Oncology +17

Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.

Ester Fonsatti, Antti Jekunen, Kalevi Kairemo et al. · PubMed · 2000 · 135 citations

Medicine, Cell Biology, Oncology +17

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P. Baum et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17